ULIPRISTALACETAT-TABLETTEN

Patent europeic · EP2365800 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2365800
Numer da la dumonda
EP09764855
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
08-12-2009
Publitgà
21-09-2011
Concedì
20-07-2016
Stritgà
25-01-2023
Motiv
Revocà en la procedura d’opposiziun
Classas IPC
A61K 9/20 (2006.01)
A61K 31/56 (2006.01)
Prioritad
US 329865 08.12.2008
Dumonda PCT
PCT/EP2009/066652 08.12.2009
Publicaziun PCT
WO2010/066749 17.06.2010
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-01-2023

    Midada

    Published in Swissreg on 25.01.2023

  2. 21-07-2021

    Stritgà, taxa betg pajada

    Published in Swissreg on 21.07.2021

  3. 20-07-2016

    Concedì

    Published in Swissreg on 20.07.2016

Partidas

Possessur

Laboratoire HRA PHARMA

Laboratoire HRA Pharma

15, rue Béranger, 75003 Paris, FR

Inventur

GAINER, Erin

F-75019 Paris, FR

GUILLARD, Hélène

F-75011 Paris, FR

GICQUEL, Denis

F-78630 Orgeval, FR

HENRION, Marianne

F-75005 Paris, FR

GNAKAMENE, Céline

F-75014 Paris, FR

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.